Chugai Pharmaceutical, headquartered in Japan, is a subsidiary of Roche, having operations in Asia, Europe and North America. This company is now ranked as a Top 50 Pharma company by Current Partnering.
Since 2009, Chugai has entered into a number of partnering deals in the areas of cancer, psychiatry, immunology, infectious diseases and metabolic diseases.
The partnering activity of this ambitious company is reviewed in this article.
The following figure shows the level of Chugai Pharmaceutical partnering deal announcements since 2009. Although you can observe peaks and dips in the partnering activity, the company continues to bolster its product strength by partnering with big companies for different technologies.
Figure 1: Chugai Pharmaceutical partnering deals 2009-2014
Source: Current Agreements, 2014
Analysis of the partnering deals shows a strong emphasis on partnerships in cancer, psychiatry, immunology, infectious diseases and metabolic therapy areas. The company’s mission to excel and emerge as the top pharmaceutical company allows it to strategically partner to fill its therapeutic pipeline products. The company partners for products like antibodies, proteomics, cancer vaccine and diagnostics technology.
The following table provides an overview of the partnering deals announced by Chugai Pharmaceutical based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Chugai Pharmaceutical 2009-2014
Figure 2: Chugai Pharmaceutical partnering deals by therapy area 2009-2014
Source: Current Agreements, 2014
Further analysis of these deals shows that Chugai Pharmaceutical has a preference for licensing, marketing and development deals. A recent strategic alliance was the licensing deal with Epivax to incorporate Epivax’s ISPRI immunogenicity screening and deimmunization technology into Chugai’s drug development toolbox- more deal details.
The following table provides an overview of the partnering deals announced by Chugai Pharmaceutical based on deal type disclosed.
Figure 3: Chugai Pharmaceutical partnering deals by deal type 2009-2014
Chugai Pharmaceutical partnering at Current Agreements
Full details on each deal can be found at Current Agreements (subscription required)
Or purchase report: Partnering Agreements with Chugai Pharmaceutical 2009-2014
No M&A activity for Chugai Pharmaceutical
Available reports from Current Partnering
Report: Partnering Agreements with Chugai Pharmaceutical 2009-2014
Available resources for deal coverage for Chugai Pharmaceutical
Read: more on Chugai Pharmaceutical company profile, recent partnering, M&A and financing news and articles
Report: Finding Biopharma Licensing and Collaboration Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk